Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$106

Avg closing price
Price range

8 Ron Baron Neurocrine Biosciences Trades

Ron Baron started to build up the position in Neurocrine Biosciences in Q2 2018 and continued to invest until Q3 2020. Since then they sold 264 Thousand shares. The investor sold all their shares in Q4 2020 and doesn't own any shares in Neurocrine Biosciences anymore.

Avg closing price
Price range
Sold -264 Thousand shares Q4 2020
Avg closing price $96.59
Price range $86.91 - $108.33
Increased shares by 67.4% (+106 Thousand shares) Q3 2020
Avg closing price $115.68
Price range $96.16 - $135.15
Increased shares by 42.4% (+46.9 Thousand shares) Q2 2020
Avg closing price $110.51
Price range $85.09 - $130.36
Increased shares by 249.9% (+79 Thousand shares) Q1 2020
Avg closing price $97.87
Price range $75.11 - $113.76
Increased shares by 0.6% (+200 shares) Q3 2019
Avg closing price $93.43
Price range $83.82 - $101.50
Increased shares by 1.2% (+369 shares) Q4 2018
Avg closing price $95.81
Price range $68.32 - $124.36
Increased shares by 4.5% (+1.33 Thousand shares) Q3 2018
Avg closing price $113.46
Price range $98.88 - $125.85
New holding (+29.7 Thousand shares) Q2 2018
Avg closing price $89.51
Price range $75.30 - $105.99

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!